Zenon W. C. Yeung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zenon W. C. Yeung has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Jason Ying Kuen Chan
Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China
5 shared publications - Alex K. F. Lee
Department of Otorhinolaryngology, Head and Neck Surgery Tseung Kwan O Hospital Hong Kong Hong Kong
2 shared publications Michael C. F. Tong
The Chinese University of Hong Kong
2 shared publicationsA.K.F. Lee
Department of Otorhinolaryngology-Head and Neck Surgery, United Christian Hospital and Tseung Kwan O Hospital, 2, Po Ning Lane, Tseung Kwan O, New Territories, Hong Kong
1 shared publicationAlexander C. Vlantis
Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong, Kong SAR, China
1 shared publicationBecky Y. T. Chan
Department of Speech Therapy Prince of Wales Hospital Shatin Hong Kong
1 shared publication
Latest Publications
- Open Access
- 18 June 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (3) , e1276
Radiofrequency ablation compared to surgery for thyroid nodules: A case for office based treatment
Objective: We aim to evaluate the safety and effectiveness of radiofrequency ablation (RFA) for benign thyroid nodules by ENT surgeons and to compare it to conventional hemithyroidectomy in the public healthcare, operating theater contained setting.Methods: 50 patients who underwent a single session of RFA for symptomatic benign thyroid nodules in Prince of Wales Hospital and Tseung Kwan O Hospital in Hong Kong from 2020 to 2022 were evaluated. Objective outcomes including nodule volume, volume reduction rate (VRR) and complications were recorded. Subjective response in the form of a 0–10 point scale for patient symptoms including obstructive, cosmetic, pain and satisfaction scores were collected.Results: Significant reduction in mean VRR was found at 3, 6 and 12 months post treatment, accompanied by a significant reduction in the mean obstructive and cosmetic symptom scores. Comparing with conventional hemithyroidectomy, the RFA group had a significantly shorter mean procedure time and lower rate of complications. Estimated cost to patient for RFA was found to be less than half of that of hemithyroidectomy.Conclusion: RFA is a safe and effective treatment modality for benign thyroid nodules by ENT surgeons with advantages of being a scarless local anesthetic procedure with shorter procedure time, lower complication rate and lower cost to patient compared to hemithyroidectomy. In Hong Kong, where most of the population is treated in the public sector, there are limited resources, often with high caseload burden and long operation waiting times. Therefore, RFA is an office‐based treatment that serves as a valuable alternative to hemithyroidectomy for benign nodules, especially in lower resource settings.Level of evidence: 3.
- 18 June 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (3) , e1276
Open AccessRadiofrequency ablation compared to surgery for thyroid nodules: A case for office based treatment
Objective: We aim to evaluate the safety and effectiveness of radiofrequency ablation (RFA) for benign thyroid nodules by ENT surgeons and to compare it to conventional hemithyroidectomy in the public healthcare, operating theater contained setting.Methods: 50 patients who underwent a single session of RFA for symptomatic benign thyroid nodules in Prince of Wales Hospital and Tseung Kwan O Hospital in Hong Kong from 2020 to 2022 were evaluated. Objective outcomes including nodule volume, volume reduction rate (VRR) and complications were recorded. Subjective response in the form of a 0–10 point scale for patient symptoms including obstructive, cosmetic, pain and satisfaction scores were collected.Results: Significant reduction in mean VRR was found at 3, 6 and 12 months post treatment, accompanied by a significant reduction in the mean obstructive and cosmetic symptom scores. Comparing with conventional hemithyroidectomy, the RFA group had a significantly shorter mean procedure time and lower rate of complications. Estimated cost to patient for RFA was found to be less than half of that of hemithyroidectomy.Conclusion: RFA is a safe and effective treatment modality for benign thyroid nodules by ENT surgeons with advantages of being a scarless local anesthetic procedure with shorter procedure time, lower complication rate and lower cost to patient compared to hemithyroidectomy. In Hong Kong, where most of the population is treated in the public sector, there are limited resources, often with high caseload burden and long operation waiting times. Therefore, RFA is an office‐based treatment that serves as a valuable alternative to hemithyroidectomy for benign nodules, especially in lower resource settings.Level of evidence: 3.
- 30 October 2022
- Published by Springer Nature
- p. 107-117
A Comprehensive Telemedicine Service in Hong Kong Provided Through a Mobile Application
- 30 October 2022
- Published by Springer Nature
- p. 107-117
A Comprehensive Telemedicine Service in Hong Kong Provided Through a Mobile Application
- 1 September 2021
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 138, 43-44
Radiofrequency ablation of benign thyroid nodules (with video)
- 1 September 2021
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 138, 43-44
Radiofrequency ablation of benign thyroid nodules (with video)
- 1 September 2021
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 138, 63-64
Interventional sialendoscopy
- 1 September 2021
- Published by Elsevier in European Annals of Otorhinolaryngology, Head and Neck Diseases
- Vol. 138, 63-64
Interventional sialendoscopy
- 11 May 2020
- Published by Wiley in Head & Neck
- Vol. 42 (7) , 1491-1496
Management of dysphagia in the patient with head and neck cancer during COVID‐19 pandemic: Practical strategy
The global pandemic of 2019 novel coronavirus disease (COVID‐19) has tremendously altered routine medical service provision and imposed unprecedented challenges to the health care system. This impacts patients with dysphagia complications caused by head and neck cancers. As this pandemic of COVID‐19 may last longer than severe acute respiratory syndrome (SARS) in 2003, a practical workflow for managing dysphagia is crucial to ensure a safe and efficient practice to patients and health care personnel. This document provides clinical practice guidelines based on available evidence to date to balance the risks of SARS‐CoV‐2 exposure with the risks associated with dysphagia. Critical considerations include reserving instrumental assessments for urgent cases only, optimizing the noninstrumental swallowing evaluation, appropriate use of personal protective equipment (PPE), and use of telehealth when appropriate. Despite significant limitations in clinical service provision during the pandemic of COVID‐19, a safe and reasonable dysphagia care pathway can still be implemented with modifications of setup and application of newer technologies.
- 11 May 2020
- Published by Wiley in Head & Neck
- Vol. 42 (7) , 1491-1496
Management of dysphagia in the patient with head and neck cancer during COVID‐19 pandemic: Practical strategy
The global pandemic of 2019 novel coronavirus disease (COVID‐19) has tremendously altered routine medical service provision and imposed unprecedented challenges to the health care system. This impacts patients with dysphagia complications caused by head and neck cancers. As this pandemic of COVID‐19 may last longer than severe acute respiratory syndrome (SARS) in 2003, a practical workflow for managing dysphagia is crucial to ensure a safe and efficient practice to patients and health care personnel. This document provides clinical practice guidelines based on available evidence to date to balance the risks of SARS‐CoV‐2 exposure with the risks associated with dysphagia. Critical considerations include reserving instrumental assessments for urgent cases only, optimizing the noninstrumental swallowing evaluation, appropriate use of personal protective equipment (PPE), and use of telehealth when appropriate. Despite significant limitations in clinical service provision during the pandemic of COVID‐19, a safe and reasonable dysphagia care pathway can still be implemented with modifications of setup and application of newer technologies.
- 7 May 2020
- Published by Wiley in Head & Neck
- Vol. 42 (7) , 1454-1459
Mitigation of head and neck cancer service disruption during COVID‐19 in Hong Kong through telehealth and multi‐institutional collaboration
The 2019 novel coronavirus disease (COVID‐19) pandemic has been spreading worldwide at an alarming rate. Health‐care workers have been confronted with the challenge of not only treating patients with the virus, but also managing the disruption of health‐care services caused by COVID‐19. In anticipation of outbreak, clinic sessions and operation theater lists have been actively cut back since February 2020 to reduce hospital admissions and clinic attendances. This has severely disrupted health‐care services, leading to accumulating clinic caseload and substantial delays for operations. The head and neck cancer service has been faced with the difficult task of managing the balance between infection risk to health‐care providers and the risk of disease progression from prolonged waiting times. We share our experience in Hong Kong on the mitigation of head and neck cancer service disruption through telehealth and multi‐institution collaboration.
- 7 May 2020
- Published by Wiley in Head & Neck
- Vol. 42 (7) , 1454-1459
Mitigation of head and neck cancer service disruption during COVID‐19 in Hong Kong through telehealth and multi‐institutional collaboration
The 2019 novel coronavirus disease (COVID‐19) pandemic has been spreading worldwide at an alarming rate. Health‐care workers have been confronted with the challenge of not only treating patients with the virus, but also managing the disruption of health‐care services caused by COVID‐19. In anticipation of outbreak, clinic sessions and operation theater lists have been actively cut back since February 2020 to reduce hospital admissions and clinic attendances. This has severely disrupted health‐care services, leading to accumulating clinic caseload and substantial delays for operations. The head and neck cancer service has been faced with the difficult task of managing the balance between infection risk to health‐care providers and the risk of disease progression from prolonged waiting times. We share our experience in Hong Kong on the mitigation of head and neck cancer service disruption through telehealth and multi‐institution collaboration.
- Open Access
- 27 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Neck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma
The aim of this study was to evaluate the impact of lymph node status from neck dissection pathological specimens on the survival for isolated regional nodal recurrence or persistence after primary treatment of nasopharyngeal carcinoma. Through a retrospective cohort study performed in an academic tertiary referral hospital in Hong Kong. Forty-six patients who underwent a salvage neck dissection between June 2001 and January 2013 for isolated regionally recurrent or persistent nasopharyngeal carcinoma was performed. Informed consent was waived for this retrospective study by The Joint CUHK-NTEC CREC. In the study forty-six patients had a salvage neck dissection for nodal failure with a mean age of 53 and 74% (34) were male. With a mean follow-up of 45.3 months, Overall survival, disease specific survival, loco-regional recurrence free survival, and regional recurrence free survival were 56.5%, 73.9%, 87.0%, and 91.3% respectively. For both univariate and multivariate analysis, patients with a number of positive lymph nodes more than 5 and a lymph node density more than 20% were significantly associated with poorer overall survival. Extracapsular spread and pathological cervical lymph node staging did not have an association with poorer survival. In conclusion, an absolute number of positive lymph nodes more than five and a lymph node density more than 20% were potentially useful prognostic factors affecting survival following a neck dissection for regional residual or recurrent nasopharyngeal carcinoma.
- 27 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Open AccessNeck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma
The aim of this study was to evaluate the impact of lymph node status from neck dissection pathological specimens on the survival for isolated regional nodal recurrence or persistence after primary treatment of nasopharyngeal carcinoma. Through a retrospective cohort study performed in an academic tertiary referral hospital in Hong Kong. Forty-six patients who underwent a salvage neck dissection between June 2001 and January 2013 for isolated regionally recurrent or persistent nasopharyngeal carcinoma was performed. Informed consent was waived for this retrospective study by The Joint CUHK-NTEC CREC. In the study forty-six patients had a salvage neck dissection for nodal failure with a mean age of 53 and 74% (34) were male. With a mean follow-up of 45.3 months, Overall survival, disease specific survival, loco-regional recurrence free survival, and regional recurrence free survival were 56.5%, 73.9%, 87.0%, and 91.3% respectively. For both univariate and multivariate analysis, patients with a number of positive lymph nodes more than 5 and a lymph node density more than 20% were significantly associated with poorer overall survival. Extracapsular spread and pathological cervical lymph node staging did not have an association with poorer survival. In conclusion, an absolute number of positive lymph nodes more than five and a lymph node density more than 20% were potentially useful prognostic factors affecting survival following a neck dissection for regional residual or recurrent nasopharyngeal carcinoma.